189 related articles for article (PubMed ID: 29679292)
41. Novel radioiodinated desvenlafaxine-loaded lipid nanocapsule for brain delivery.
Ayoub VR; Abdel-Mottaleb MMA; Ibrahem IT; Motaleb MA; Geneidi AS
Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300618. PubMed ID: 38161231
[TBL] [Abstract][Full Text] [Related]
42. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
[TBL] [Abstract][Full Text] [Related]
43. Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity.
Kabil MF; Mahmoud MY; Bakr AF; Zaafar D; El-Sherbiny IM
Life Sci; 2022 Sep; 305():120731. PubMed ID: 35753435
[TBL] [Abstract][Full Text] [Related]
44. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel.
Lacoeuille F; Hindre F; Moal F; Roux J; Passirani C; Couturier O; Cales P; Le Jeune JJ; Lamprecht A; Benoit JP
Int J Pharm; 2007 Nov; 344(1-2):143-9. PubMed ID: 17646066
[TBL] [Abstract][Full Text] [Related]
45. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression.
de Castro Leão M; Raffin Pohlmann A; de Cristo Soares Alves A; Helena Poliselli Farsky S; Klimuk Uchiyama M; Araki K; Sandri S; Stanisçuaski Guterres S; Alves Castro I
Eur J Pharm Biopharm; 2021 Feb; 159():99-107. PubMed ID: 33358940
[TBL] [Abstract][Full Text] [Related]
46. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
[TBL] [Abstract][Full Text] [Related]
47. Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.
Schultze E; Ourique A; Yurgel VC; Begnini KR; Thurow H; de Leon PM; Campos VF; Dellagostin OA; Guterres SR; Pohlmann AR; Seixas FK; Beck RC; Collares T
Eur J Pharm Biopharm; 2014 May; 87(1):55-63. PubMed ID: 24525073
[TBL] [Abstract][Full Text] [Related]
48. pH-responsive hyaluronic acid nanoparticles coloaded with sorafenib and cisplatin for treatment of hepatocellular carcinoma.
Zhang W; Cai J; Wu B; Shen Z
J Biomater Appl; 2019 Aug; 34(2):219-228. PubMed ID: 31084233
[No Abstract] [Full Text] [Related]
49. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
50. Effects of chitosan-coated lipid-core nanocapsules on bovine sperm cells.
de Castro Jorge Silva A; Remirão MH; Lucas CG; Domingues WB; Silveira T; Paschoal JD; Jornada DS; Corcine CD; Junior AS; Prado WA; Campos VF; Seixas FK; Guterres SS; Pohlmann AR; Collares T
Toxicol In Vitro; 2017 Apr; 40():214-222. PubMed ID: 28130145
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
52. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
[TBL] [Abstract][Full Text] [Related]
53. The gastrointestinal stability of lipid nanocapsules.
Roger E; Lagarce F; Benoit JP
Int J Pharm; 2009 Sep; 379(2):260-5. PubMed ID: 19524655
[TBL] [Abstract][Full Text] [Related]
54. Preparation and evaluation of folate-modified lipid nanocapsules for quercetin delivery.
Ding B; Chen P; Kong Y; Zhai Y; Pang X; Dou J; Zhai G
J Drug Target; 2014 Jan; 22(1):67-75. PubMed ID: 24099639
[TBL] [Abstract][Full Text] [Related]
55. Enhancing the therapeutic effect via elimination of hepatocellular carcinoma stem cells using Bmi1 siRNA delivered by cationic cisplatin nanocapsules.
Yang T; Chen Y; Zhao P; Xue H; You J; Li B; Liu Y; He C; Zhang X; Fan L; Lee RJ; Li L; Ma X; Xu C; Xiang G
Nanomedicine; 2018 Oct; 14(7):2009-2021. PubMed ID: 29842934
[TBL] [Abstract][Full Text] [Related]
56. Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death.
Griveau A; Bejaud J; Anthiya S; Avril S; Autret D; Garcion E
Int J Pharm; 2013 Oct; 454(2):765-74. PubMed ID: 23732394
[TBL] [Abstract][Full Text] [Related]
57. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
[TBL] [Abstract][Full Text] [Related]
58. Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment.
Safwat S; Hathout RM; Ishak RA; Mortada ND
J Liposome Res; 2017 Mar; 27(1):1-10. PubMed ID: 26872624
[TBL] [Abstract][Full Text] [Related]
59. Enhanced antitumor efficacy of resveratrol-loaded nanocapsules in colon cancer cells: physicochemical and biological characterization.
Feng M; Zhong LX; Zhan ZY; Huang ZH; Xiong JP
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):375-382. PubMed ID: 28165548
[TBL] [Abstract][Full Text] [Related]
60. Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity.
Leite EA; Souza CM; Carvalho-Júnior AD; Coelho LG; Lana AM; Cassali GD; Oliveira MC
Int J Nanomedicine; 2012; 7():5259-69. PubMed ID: 23091378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
